Back to 
Maverick Capital Ltd.
Maverick Capital Ltd.
LGND
2 quarters
Position history for Maverick Capital Ltd.'s holdings in Ligand Pharmaceuticals Incorporated
No. Maverick Capital exited its LGND (Ligand Pharmaceuticals) position in Q1 2020. Its Q4 2019 13F listed 16,489 shares worth $1.7M. Maverick Capital first reported LGND in Q4 2019 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$1.7M
Total Shares Change
-16,489
Quarter-by-Quarter History
Other major holders of LGND: BlackRock, Inc., Vanguard Group Inc.